Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifileucel in Previously Treated Advanced Melanoma
2025-522054-40-00Phase 2Completed
- Sponsor
- Iovance Biotherapeutics
- Start
- Nov 2025
- Modality
- Cell Therapies
- Countries
- 8
01
Overview
Phase 2, open-label, single-arm trial of lifileucel in melanoma, sponsored by Iovance Biotherapeutics. Started Nov 2025; status: completed.
02
Drugs
lifileucel
03
Conditions
melanoma
Beyond the preview
Go deeper on 2025-522054-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522054-40-00.